• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清抗 SARS-CoV-2 IgA 的存在似乎能保护初级保健工作者免受 COVID-19 的侵害。

The presence of serum anti-SARS-CoV-2 IgA appears to protect primary health care workers from COVID-19.

机构信息

Department of Clinical Microbiology, Region Västra Götaland, Sahlgrenska University Hospital, Göteborg, Sweden.

Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, Institute of Medicine, University of Gothenburg, Göteborg, Sweden.

出版信息

Eur J Immunol. 2022 May;52(5):800-809. doi: 10.1002/eji.202149655. Epub 2022 Feb 18.

DOI:10.1002/eji.202149655
PMID:35128644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9087394/
Abstract

The patterns of humoral and cellular responses to SARS-CoV-2 were studied in Swedish primary health care workers (n = 156) for 6 months during the Covid-19 pandemic. Serum IgA and IgG to SARS-CoV-2, T-cell proliferation and cytokine secretion, demographic and clinical data, PCR-verified infection, and self-reported symptoms were monitored. The multivariate method OPLS-DA was used to identify immune response patterns coupled to protection from Covid-19. Contracting Covid-19 was associated with SARS-CoV-2-specific neutralizing serum IgG, T cell, IFN-γ, and granzyme B responses to SARS-CoV-2, self-reported typical Covid-19 symptoms, male sex, higher BMI, and hypertension. Not contracting Covid-19 was associated with female sex, IgA-dominated, or no antibody responses to SARS-CoV-2, airborne allergy, and smoking. The IgG-responders had SARS-CoV-2-specific T-cell responses including a cytotoxic CD4+ T-cell population expressing CD25, CD38, CD69, CD194, CD279, CTLA-4, and granzyme B. IgA-responders with no IgG response to SARS-CoV-2 constituted 10% of the study population. The IgA responses were partially neutralizing and only seen in individuals who did not succumb to Covid-19. To conclude, serum IgG-dominated responses correlated with T-cell responses to SARS-CoV-2 and PCR-confirmed Covid-19, whereas IgA-dominated responses correlated with not contracting the infection.

摘要

在新冠疫情期间,对瑞典初级保健工作者(n = 156)进行了 6 个月的 SARS-CoV-2 体液和细胞反应模式研究。监测了血清 IgA 和 IgG 对 SARS-CoV-2、T 细胞增殖和细胞因子分泌、人口统计学和临床数据、PCR 证实的感染和自我报告的症状。使用多元方法 OPLS-DA 来识别与新冠保护相关的免疫反应模式。感染新冠与 SARS-CoV-2 特异性中和血清 IgG、T 细胞、IFN-γ 和 granzyme B 对 SARS-CoV-2 的反应、自我报告的典型新冠症状、男性、更高的 BMI 和高血压有关。未感染新冠与女性、对 SARS-CoV-2 呈 IgA 主导或无抗体反应、空气传播过敏和吸烟有关。IgG 应答者具有 SARS-CoV-2 特异性 T 细胞反应,包括表达 CD25、CD38、CD69、CD194、CD279、CTLA-4 和 granzyme B 的细胞毒性 CD4+ T 细胞群。对 SARS-CoV-2 无 IgG 反应的 IgA 应答者占研究人群的 10%。IgA 反应部分具有中和作用,仅见于未感染新冠的个体。总之,血清 IgG 主导的反应与 SARS-CoV-2 和 PCR 确诊的新冠感染的 T 细胞反应相关,而 IgA 主导的反应与未感染相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee8/9087394/fbc715b024e2/EJI-52--g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee8/9087394/a19593efaba2/EJI-52--g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee8/9087394/183f3794b939/EJI-52--g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee8/9087394/4513f746e594/EJI-52--g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee8/9087394/06c63701c9b4/EJI-52--g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee8/9087394/fbc715b024e2/EJI-52--g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee8/9087394/a19593efaba2/EJI-52--g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee8/9087394/183f3794b939/EJI-52--g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee8/9087394/4513f746e594/EJI-52--g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee8/9087394/06c63701c9b4/EJI-52--g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee8/9087394/fbc715b024e2/EJI-52--g002.jpg

相似文献

1
The presence of serum anti-SARS-CoV-2 IgA appears to protect primary health care workers from COVID-19.血清抗 SARS-CoV-2 IgA 的存在似乎能保护初级保健工作者免受 COVID-19 的侵害。
Eur J Immunol. 2022 May;52(5):800-809. doi: 10.1002/eji.202149655. Epub 2022 Feb 18.
2
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.COVID-19 康复者感染后 1 年的 SARS-CoV-2 特异性抗体和 T 细胞反应:一项纵向队列研究。
Lancet Microbe. 2022 May;3(5):e348-e356. doi: 10.1016/S2666-5247(22)00036-2. Epub 2022 Mar 23.
3
Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2.血清 IgG 抗 SARS-CoV-2 结合抗体水平与成人感染 SARS-CoV-2 时的 IgA 和功能性抗体水平密切相关。
Front Immunol. 2021 Oct 8;12:693462. doi: 10.3389/fimmu.2021.693462. eCollection 2021.
4
Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine.口服亚单位 SARS-CoV-2 疫苗可诱导全身中和 IgG、IgA 和细胞免疫应答,并能增强已接种疫苗产生的中和抗体应答。
Vaccine. 2022 Feb 16;40(8):1098-1107. doi: 10.1016/j.vaccine.2022.01.025. Epub 2022 Jan 19.
5
Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines.感染 SARS-CoV-2 后和接种 COVID-19 疫苗后针对 SARS-CoV-2 刺突蛋白的唾液和血清 IgA 和 IgG 反应。
Allergy Asthma Proc. 2022 Sep 1;43(5):419-430. doi: 10.2500/aap.2022.43.220045.
6
Detection of IgM, IgG, IgA and neutralizing antibody responses to SARS-CoV-2 infection and mRNA vaccination.检测针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染和mRNA疫苗接种的IgM、IgG、IgA及中和抗体反应。
J Med Microbiol. 2023 Jan;72(1). doi: 10.1099/jmm.0.001632.
7
Long-term evolution of humoral immune response after SARS-CoV-2 infection.SARS-CoV-2 感染后体液免疫反应的长期演变。
Clin Microbiol Infect. 2022 Jul;28(7):1027.e1-1027.e4. doi: 10.1016/j.cmi.2022.03.012. Epub 2022 Mar 17.
8
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.BNT162b2 新冠病毒疫苗与体液免疫应答及动力学的相关性:医护人员前瞻性、单中心、纵向队列研究。
Lancet Respir Med. 2021 Sep;9(9):999-1009. doi: 10.1016/S2213-2600(21)00220-4. Epub 2021 Jul 2.
9
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.2021 年 5 月波兰人群中对 SARS-CoV-2 具有免疫力的隐匿人群。
PLoS One. 2022 Feb 3;17(2):e0253638. doi: 10.1371/journal.pone.0253638. eCollection 2022.
10
Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.急危重症高血压患者的 SARS-CoV-2 特异性动态免疫。
Front Immunol. 2020 Dec 10;11:596684. doi: 10.3389/fimmu.2020.596684. eCollection 2020.

引用本文的文献

1
A Comprehensive Review of mRNA-based Vaccines for COVID-19, A New Era in Pharmaceuticals: Unspecified and Unknown Aspects, Effects and Challenges.新型冠状病毒肺炎mRNA疫苗综合综述:制药新时代的未明确及未知方面、影响与挑战
Curr Top Med Chem. 2025;25(12):1467-1491. doi: 10.2174/0115680266325847241121034100.
2
Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses.解析严重急性呼吸综合征冠状病毒2(SARS-CoV-2)突变对免疫的影响:从天然免疫识别到抗体和T细胞反应的见解
Front Immunol. 2024 Dec 10;15:1412873. doi: 10.3389/fimmu.2024.1412873. eCollection 2024.
3

本文引用的文献

1
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition).流式细胞术和细胞分选在免疫学研究中的应用指南(第三版)。
Eur J Immunol. 2021 Dec;51(12):2708-3145. doi: 10.1002/eji.202170126. Epub 2021 Dec 7.
2
False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases.慢性炎症性疾病患者样本的 SARS-CoV-2 血清学检测中出现假阳性结果。
Front Immunol. 2021 May 3;12:666114. doi: 10.3389/fimmu.2021.666114. eCollection 2021.
3
Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.
Application of Interferon-γ Release Assay in the Assessment of T-Cell Immunity to SARS-CoV-2 Antigens in the Cohort of Pediatric Patients with Juvenile Idiopathic Arthritis.
干扰素-γ释放试验在幼年特发性关节炎患儿队列中评估针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗原的T细胞免疫方面的应用
Children (Basel). 2024 Jun 16;11(6):736. doi: 10.3390/children11060736.
4
Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice.黏膜二价减毒活疫苗可保护小鼠免受人偏肺病毒和呼吸道合胞病毒感染。
NPJ Vaccines. 2024 Jun 19;9(1):111. doi: 10.1038/s41541-024-00899-9.
5
Influenza vaccination as a prognostic factor of humoral IgA responses to SARS-CoV-2 infection.流感疫苗接种作为体液IgA对严重急性呼吸综合征冠状病毒2感染反应的一个预后因素。
Cent Eur J Immunol. 2024;49(1):11-18. doi: 10.5114/ceji.2024.135462. Epub 2024 Feb 17.
6
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk.既往免疫可影响机体对 SARS-CoV-2 加强针疫苗接种和奥密克戎突破性感染风险的免疫应答。
Nat Commun. 2023 Sep 12;14(1):5624. doi: 10.1038/s41467-023-41342-2.
7
Vaccine-elicited B- and T-cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients.慢性肺病患者中,疫苗引发的针对新冠病毒的B细胞和T细胞免疫功能受损。
ERJ Open Res. 2023 Oct 16;9(5). doi: 10.1183/23120541.00400-2023. eCollection 2023 Sep.
8
Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2.SARS-CoV-2 疫苗 BNT162b2 加强针的保护相关因素。
Nat Commun. 2023 Jul 29;14(1):4575. doi: 10.1038/s41467-023-39816-4.
9
Characterization of SARS-CoV-2 humoral immune response in a subject with unique sampling: A case report.SARS-CoV-2 体液免疫反应在具有独特采样的个体中的特征:一例病例报告。
Immun Inflamm Dis. 2023 Jun;11(6):e910. doi: 10.1002/iid3.910.
10
Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses.重新思考针对冠状病毒、流感病毒和其他呼吸道病毒的下一代疫苗。
Cell Host Microbe. 2023 Jan 11;31(1):146-157. doi: 10.1016/j.chom.2022.11.016.
2020年疫情期间一项横断面研究:SARS-CoV-2逆转录实时聚合酶链反应(rtRT-PCR)检测呈阳性的墨西哥儿童和成人中哮喘的低患病率
Allergol Immunopathol (Madr). 2021 May 1;49(3):1-7. doi: 10.15586/aei.v49i3.7. eCollection 2021.
4
Upregulation of CCR4 in activated CD8 T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection.在严重急性 SARS-CoV-2 感染患者中,激活的 CD8 T 细胞中 CCR4 的上调表明增强了肺部归巢。
Eur J Immunol. 2021 Jun;51(6):1436-1448. doi: 10.1002/eji.202049135. Epub 2021 Apr 19.
5
Infection fatality rate of COVID-19 inferred from seroprevalence data.基于血清流行率数据推断的 COVID-19 感染病死率。
Bull World Health Organ. 2021 Jan 1;99(1):19-33F. doi: 10.2471/BLT.20.265892. Epub 2020 Oct 14.
6
Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities.针对 SARS-CoV-2 的抗体同种型多样性与血清中和能力的差异有关。
Sci Rep. 2021 Mar 10;11(1):5538. doi: 10.1038/s41598-021-84913-3.
7
Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth.吸烟者是否免受 SARS-CoV-2 感染(COVID-19)?谣言的起源。
NPJ Prim Care Respir Med. 2021 Feb 26;31(1):10. doi: 10.1038/s41533-021-00223-1.
8
Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay.在厄瓜多尔未接触过 SARS-CoV-2 的健康对照者中,使用 COVID-19 干扰素释放分析检测到预先存在的针对 SARS-CoV-2 的 T 细胞免疫。
Int J Infect Dis. 2021 Apr;105:21-25. doi: 10.1016/j.ijid.2021.02.034. Epub 2021 Feb 12.
9
Sex differences in immune responses.免疫反应中的性别差异。
Science. 2021 Jan 22;371(6527):347-348. doi: 10.1126/science.abe7199.
10
IgA dominates the early neutralizing antibody response to SARS-CoV-2.IgA 在针对 SARS-CoV-2 的早期中和抗体反应中占主导地位。
Sci Transl Med. 2021 Jan 20;13(577). doi: 10.1126/scitranslmed.abd2223. Epub 2020 Dec 7.